Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes
Marine Drugs · 2024
DOI: 10.3390/md22050210 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2024. Verfasst von Maria Elisa Giuliani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Technology Center for Aging Research and Geriatric Mouse Clinic, IRCCS INRCA, 60121 Ancona, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Aquatic Organisms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Ministero dell'Università e della Ricerca, Next Generation EU—“Age-It—Ageing well in an ageing society” project.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Ageing represents a main risk factor for several pathologies. Among them, cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM) are predominant in the elderly population and often require prolonged use of multiple drugs due to their chronic nature and the high proportion of co-morbidities. Hence, research is constantly looking for novel, effective molecules to treat CVD and T2DM with minimal side effects. Marine active compounds, holding a great diversity of chemical structures and biological properties, represent interesting therapeutic candidates to treat these age-related diseases. This review summarizes the current state of research on marine compounds for the treatment of CVD and T2DM, from pre-clinical studies to clinical investigations and approved drugs, highlighting the potential of marine compounds in the development of new therapies, together with the limitations in translating pre-clinical results into human application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Technology Center for Aging Research and Geriatric Mouse Clinic, IRCCS INRCA, 60121 Ancona, Italy.
- Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico "Carlo Besta", 20126 Milano, Italy.
- Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
ORCID-Profile: Maria Elisa Giuliani, Giorgia Bigossi, Serena Marcozzi, Dario Brunetti, Marco Malavolta
Förderung
- Italian Ministry of Health
- Ministero dell'Università e della Ricerca
- Next Generation EU—“Age-It—Ageing well in an ageing society” project
Zitieren
APA
Giuliani, M. E., Bigossi, G., Lai, G., Marcozzi, S., Brunetti, D., & Malavolta, M. (2024). Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes. Marine Drugs. https://doi.org/10.3390/md22050210
Vancouver
Giuliani ME, Bigossi G, Lai G, Marcozzi S, Brunetti D, Malavolta M. Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes. Marine Drugs. 2024. doi:10.3390/md22050210
BibTeX
@article{Giuliani2024,
author = {Giuliani, Maria Elisa and Bigossi, Giorgia and Lai, Giovanni and Marcozzi, Serena and Brunetti, Dario and Malavolta, Marco},
title = {Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22050210}
}
EUVIMED